Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""van Boxtel, W."" wg kryterium: Wszystkie pola


Tytuł :
68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer.
Autorzy :
Uijen MJM; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Boxtel W; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Herpen CML; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
Gotthardt M; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
Nagarajah J
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. 716-718.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Oligopeptides*
Positron Emission Tomography Computed Tomography*
Carcinoma, Adenoid Cystic/*pathology
Edetic Acid/*analogs & derivatives
Heart Neoplasms/*diagnostic imaging
Heart Neoplasms/*secondary
Aged ; Humans ; Male
Czasopismo naukowe
Tytuł :
Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
Jonker MA; Department of Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
van Engen-van Grunsven ICH; Department of Pathology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Corporate Authors :
PALGA Group
Źródło :
Oral oncology [Oral Oncol] 2020 Nov; Vol. 110, pp. 105018. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article
MeSH Terms :
Cadherins/*genetics
Carcinoma, Ductal/*etiology
Proteasome Endopeptidase Complex/*metabolism
Proto-Oncogene Proteins c-met/*genetics
Salivary Gland Neoplasms/*etiology
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Cadherins/metabolism ; Carcinoma, Ductal/diagnosis ; Carcinoma, Ductal/mortality ; Carcinoma, Ductal/therapy ; Disease Susceptibility ; Female ; Gene Expression ; Humans ; Immunohistochemistry ; In Situ Hybridization ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Proto-Oncogene Proteins c-met/metabolism ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Salivary Gland Neoplasms/diagnosis ; Salivary Gland Neoplasms/mortality ; Salivary Gland Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Verhaegh GW; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Engen-van Grunsven IA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Strijp D; Philips Research, Eindhoven, The Netherlands.
Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ligtenberg MJ; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
van Zon HB; Philips Research, Eindhoven, The Netherlands.
Hendriksen Y; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Keizer D; Molecular Pathway Diagnostics, Philips Healthworks, Eindhoven, The Netherlands.
van de Stolpe A; Philips Research, Eindhoven, The Netherlands.
Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Herpen CM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Jun 01; Vol. 146 (11), pp. 3196-3206. Date of Electronic Publication: 2019 Dec 12.
Typ publikacji :
Journal Article
MeSH Terms :
Androgen Antagonists/*therapeutic use
Receptors, Androgen/*deficiency
Receptors, Androgen/*metabolism
Salivary Gland Neoplasms/*drug therapy
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics ; Adult ; Aged ; Aldo-Keto Reductase Family 1 Member C3/genetics ; Disease-Free Survival ; Female ; Humans ; Male ; Membrane Proteins/genetics ; Middle Aged ; Receptor, ErbB-2/genetics ; Receptors, Androgen/genetics ; Salivary Ducts/pathology ; Salivary Gland Neoplasms/pathology ; Steroid 17-alpha-Hydroxylase/genetics
Czasopismo naukowe
Tytuł :
Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands.
Lütje S; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
van Engen-van Grunsven ICH; Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands.
Verhaegh GW; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Schalken JA; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Jonker MA; Department of Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.; Department of Nuclear Medicine, Technical University Munich, Germany.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands.
Pokaż więcej
Źródło :
Theranostics [Theranostics] 2020 Jan 12; Vol. 10 (5), pp. 2273-2283. Date of Electronic Publication: 2020 Jan 12 (Print Publication: 2020).
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Adenoid Cystic/*diagnostic imaging
Carcinoma, Ductal/*metabolism
Edetic Acid/*analogs & derivatives
Oligopeptides/*pharmacokinetics
Positron Emission Tomography Computed Tomography/*methods
Adult ; Aged ; Antigens, Surface/metabolism ; Carcinoma, Ductal/therapy ; Edetic Acid/administration & dosage ; Edetic Acid/pharmacokinetics ; Edetic Acid/therapeutic use ; Female ; Glutamate Carboxypeptidase II/metabolism ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Neoplasm Metastasis/diagnostic imaging ; Neoplasm Metastasis/pathology ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Oligopeptides/administration & dosage ; Oligopeptides/therapeutic use ; Prospective Studies ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/pharmacokinetics ; Radiopharmaceuticals/therapeutic use ; Salivary Ducts/pathology ; Salivary Gland Neoplasms/pathology
Czasopismo naukowe
Tytuł :
New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.
Autorzy :
van Boxtel, W. (AUTHOR)
Bulten, B. F. (AUTHOR)
Mavinkurve-Groothuis, A. M. C. (AUTHOR)
Bellersen, L. (AUTHOR)
Mandigers, C. M. P. W. (AUTHOR)
Joosten, L. A. B. (AUTHOR)
Kapusta, L. (AUTHOR)
de Geus-Oei, L. F. (AUTHOR)
van Laarhoven, H. W. M. (AUTHOR)
Pokaż więcej
Źródło :
Biomarkers. Mar2015, Vol. 20 Issue 2, p143-148. 6p.
Czasopismo naukowe
Tytuł :
Advances and challenges in precision medicine in salivary gland cancer.
Autorzy :
Lassche G; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, the Netherlands.
van Boxtel W; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, the Netherlands.
Ligtenberg MJL; Radboud University Medical Center, Department of Human Genetics, Nijmegen, the Netherlands; Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands.
van Engen-van Grunsven ACH; Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands.
van Herpen CML; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Cancer treatment reviews [Cancer Treat Rev] 2019 Nov; Vol. 80, pp. 101906. Date of Electronic Publication: 2019 Oct 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Salivary Gland Neoplasms/*classification
Salivary Gland Neoplasms/*therapy
Gene Expression Profiling ; Humans ; Immunohistochemistry ; Molecular Targeted Therapy ; Precision Medicine ; Salivary Gland Neoplasms/genetics ; Salivary Gland Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
Improving survival in salivary duct cancer with adjuvant androgen deprivation therapy.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Herpen C; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2019 Jun 11; Vol. 10 (39), pp. 3833-3834. Date of Electronic Publication: 2019 Jun 11 (Print Publication: 2019).
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Asymmetries in Gait and Balance Control After Ankle Arthrodesis.
Autorzy :
Kerkhoff YRA; Resident, Orthopaedic Surgery, Department of Orthopaedics, Sint Maartenskliniek, Nijmegen, The Netherlands. Electronic address: .
van Boxtel W; Resident, Orthopaedic Surgery, Department of Orthopaedics, Sint Maartenskliniek, Nijmegen, The Netherlands.
Louwerens JWK; Orthopaedic Surgeon, Department of Orthopaedics, Sint Maartenskliniek, Nijmegen, The Netherlands.
Keijsers NLW; Senior Researcher, Research Department, Sint Maartenskliniek, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons [J Foot Ankle Surg] 2018 Sep - Oct; Vol. 57 (5), pp. 899-903.
Typ publikacji :
Journal Article
MeSH Terms :
Ankle Joint*
Arthrodesis*
Gait/*physiology
Postural Balance/*physiology
Range of Motion, Articular/*physiology
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Weight-Bearing
Czasopismo naukowe
Tytuł :
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Autorzy :
Boon E; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Bel M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
van Es RJJ; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Eerenstein SEJ; Department of Otolaryngology/Head, Neck Surgery VU University Medical Center, Amsterdam, The Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology/Head and Neck surgery Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
van den Brekel MWM; Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.
van der Velden LA; Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Otorhinolaryngology and Head and Neck surgery, Leiden University Medical Center, Leiden, The Netherlands.
Witjes MJH; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Hoeben A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Bloemena E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Smit LA; Department of Pathology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.
Oosting SF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jonker MA; Department for Health evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Flucke UE; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Corporate Authors :
PALGA Group
Źródło :
International journal of cancer [Int J Cancer] 2018 Aug 15; Vol. 143 (4), pp. 758-766. Date of Electronic Publication: 2018 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma/*pathology
Salivary Ducts/*pathology
Salivary Gland Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Carcinoma/surgery ; Carcinoma/therapy ; Chemoradiotherapy, Adjuvant ; Disease-Free Survival ; Factor Analysis, Statistical ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Metastasis ; Netherlands ; Palliative Care ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Androgen/metabolism ; Recurrence ; Salivary Ducts/surgery ; Salivary Gland Neoplasms/radiotherapy ; Salivary Gland Neoplasms/surgery ; Salivary Gland Neoplasms/therapy ; Survival Rate
Czasopismo naukowe
Tytuł :
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
Autorzy :
Boon E; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Buter J; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology/Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Es RJJ; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Bel M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Fiets E; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Oosting SF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Hoeben A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
Tesselaar MET; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jonker MA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Flucke UE; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.
van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Corporate Authors :
Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) Group
Źródło :
Head & neck [Head Neck] 2018 Mar; Vol. 40 (3), pp. 605-613. Date of Electronic Publication: 2017 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Androgen Antagonists/*therapeutic use
Salivary Ducts/*pathology
Salivary Gland Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Netherlands ; Receptors, Androgen/metabolism ; Registries ; Retrospective Studies ; Salivary Gland Neoplasms/mortality ; Salivary Gland Neoplasms/pathology ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
Boon E; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
Weijs WLJ; Department of Oral and Maxillofacial Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
van den Hoogen FJA; Department of Otorhinolaryngology/Head and Neck Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
Flucke UE; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2017 Sep; Vol. 72, pp. 198-200. Date of Electronic Publication: 2017 Jun 30.
Typ publikacji :
Letter; Comment
MeSH Terms :
Maytansine*
Trastuzumab*
Antibodies, Monoclonal, Humanized ; Antineoplastic Agents ; Antineoplastic Combined Chemotherapy Protocols ; Breast Neoplasms ; Docetaxel ; Receptor, ErbB-2 ; Salivary Ducts ; Taxoids
Opinia redakcyjna
Tytuł :
The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria.
Autorzy :
Rooper LM; Departments of Pathology.; Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Mansour M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Yonescu R; Departments of Pathology.
Oliai BR; ProPath.
Bishop JA; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
Westra WH; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2021 Jun 01; Vol. 45 (6), pp. 753-764.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Immunohistochemistry*
Terminology as Topic*
Adenocarcinoma/*chemistry
Biomarkers, Tumor/*analysis
Salivary Gland Neoplasms/*chemistry
Adenocarcinoma/classification ; Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Child ; Disease-Free Survival ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Male ; Middle Aged ; Neoplasm Grading ; Predictive Value of Tests ; Salivary Gland Neoplasms/classification ; Salivary Gland Neoplasms/genetics ; Salivary Gland Neoplasms/pathology ; Tissue Array Analysis ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
The tumor immune contexture of salivary duct carcinoma.
Autorzy :
Schvartsman G; Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Bell D; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Rubin ML; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Tetzlaff M; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Hanna E; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Lee JJ; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Weber R; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Glisson BS; Department of Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Ferrarotto R; Department of Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2021 Apr; Vol. 43 (4), pp. 1213-1219. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Ductal*
Salivary Gland Neoplasms*
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Humans ; Middle Aged ; Receptors, Androgen ; Salivary Ducts
Czasopismo naukowe
Tytuł :
Outcomes of carcinoma ex pleomorphic adenoma compared to de novo adenocarcinoma of major salivary glands.
Autorzy :
Patel EJ; Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA.
Oliver JR; Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA.
Liu C; Department of Pathology, NYU Langone Health, New York, New York, USA.
Tam M; Department of Radiation Oncology, NYU Langone Health, New York, New York, USA.
Givi B; Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Feb; Vol. 123 (2), pp. 446-455. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*mortality
Adenoma, Pleomorphic/*mortality
Salivary Gland Neoplasms/*mortality
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Adenoma, Pleomorphic/pathology ; Adenoma, Pleomorphic/therapy ; Aged ; Cohort Studies ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Salivary Gland Neoplasms/pathology ; Salivary Gland Neoplasms/therapy ; Survival Rate
Czasopismo naukowe
Tytuł :
Molecular patterns in salivary duct carcinoma identify prognostic subgroups.
Autorzy :
Mueller SA; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia. .; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia. .; Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. .
Gauthier MA; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia.; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia.; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
Blackburn J; Cancer Research Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Grady JP; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia.
Kraitsek S; Department of Medical Genomics, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.
Hajdu E; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia.
Dettmer MS; Institute of Pathology, University of Bern, Bern, Switzerland.
Dahlstrom JE; Department of Anatomical Pathology, ACT Pathology, Canberra Hospital and Australian National University Medical School, College of Health and Medicine, Woden, ACT, Australia.
Lee CS; Centre for Oncology Education and Research Translation (CONCERT), Liverpool, NSW, Australia.; Department of Anatomical Pathology, Liverpool Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Discipline of Pathology, Western Sydney University, Sydney, NSW, Australia.; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.
Luk PP; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.
Yu B; Department of Medical Genomics, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.
Giger R; Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Kummerfeld S; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Clark JR; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Institute of Academic Surgery, University of Sydney, Sydney, NSW, Australia.
Gupta R; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.
Cowley MJ; Kinghorn Cancer Centre and Garvan Institute of Medical Research, Sydney, NSW, Australia.; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2020 Oct; Vol. 33 (10), pp. 1896-1909. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*genetics
Carcinoma, Ductal/*genetics
Salivary Gland Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma.
Autorzy :
Cheng, Nai-Ming (AUTHOR)
Hsieh, Cheng-En (AUTHOR)
Fang, Yu-Hua Dean (AUTHOR)
Liao, Chun-Ta (AUTHOR)
Ng, Shu-Hang (AUTHOR)
Wang, Hung-Ming (AUTHOR)
Chou, Wen-Chi (AUTHOR)
Lin, Chien-Yu (AUTHOR)
Yen, Tzu-Chen (AUTHOR)
Pokaż więcej
Źródło :
EJNMMI Research. 7/6/2020, Vol. 10 Issue 1, p1-12. 12p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies